| Author | Title | Source | Year |
| Chi-Kuei Hsu, Ching-Yi Chen, Wang-Chun Chen, Chih-Cheng Lai, Shun-Hsing Hung, Wei-Ting Lin. | The effect of sofosbuvir-based treatment on the clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. | Int J Antimicrob Agents. 2022 Feb 5:106545. doi: 10.1016/j.ijantimicag.2022.106545. | 2022 |
| Chi-Lun Tsai, Chih-Cheng Lai, Ching-Yi Chen, Ho-Sheng Lee. | The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis. | Expert Rev Anti Infect Ther. 2022 Nov 18. doi: 10.1080/14787210.2022.2150165. | 2022 |
| Ching-Yi Chen, Wang-Chun Chen, Chi-Kuei Hsu, Chien-Ming Chao, Chih-Cheng Lai. | The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. | J Infect Public Health. 2022 Jul 7;15(8):896-901. doi: 10.1016/j.jiph.2022.07.001. | 2022 |
| Chih-Cheng Lai, Wang-Chun Chen, Ching-Yi Chen, Yu-Feng Wei. | The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. | Expert Rev Anti Infect Ther. 2022 Jul 7:1-8. doi: 10.1080/14787210.2022.2098112. | 2022 |
| Chao-Hsien Chen, Cheng-Yi Wang, Ya-Hui Wang, Ching-Yi Chen, Kuang-Hung Chen, Chih-Cheng Lai, Yu-Feng Wei, Pin-Kuei Fu. | The effect of inhaled corticosteroids on the outcomes of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. | Expert Rev Clin Pharmacol. 2022 Jul 10:1-8. doi: 10.1080/17512433.2022.2094769. | 2022 |
| Ching-Yi Chen, Chi-Hsien Huang, Wang-Chun Chen, Ming-Shyan Huang, Yu-Feng Wei. | Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis. | Int Immunopharmacol. 2022 May 19;108:108848. doi: 10.1016/j.intimp.2022.108848. | 2022 |
| Wang-Chun Chen, Chi-Kuei Hsu, Ching-Yi Chen, Chih-Cheng Lai, Shun-Hsing Hung, Wei-Ting Lin. | Clinical efficacy and safety of interferon-β-containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. | Expert Rev Anti Infect Ther. 2022 May;20(5):741-747. doi: 10.1080/14787210.2022.2004118. | 2022 |
| Ching-Yi Chen, Wang-Chun Chen, Jung-Yueh Chen, Chih-Cheng Lai, Yu-Feng Wei. | Comparison of clinically indicated replacement and routine replacement of peripheral intravenous catheters: A systematic review and meta-analysis of randomized controlled trials. | Front Med (Lausanne). 2022 Aug 12;9:964096. doi: 10.3389/fmed.2022.964096. | 2022 |
| Chi-Kuei Hsu, Ching-Yi Chen, Wang-Chun Chen, Chien-Ming Chao, Chih-Cheng Lai. | Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: A systematic review and meta-analysis of randomized controlled trials. | Expert Rev Anti Infect Ther. 2022 Mar;20(3):435-444. doi: 10.1080/14787210.2022.1984880. Epub 2021 Oct 6.t. | 2022 |
| Ching-Yi Chen, Wang-Chun Chen, Chao-Ming Hung, Yu-Feng Wei. | Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer - a meta-analysis. | Immunotherapy. 2021 Oct;13(14):1165-1177. doi: 10.2217/imt-2021-0135. Epub 2021 Jul 15. | 2021 |
| Ching-Yi Chen, Wang-Chun Chen, Chih-Cheng Lai, Tzu-Ping Shih, Hung-Jen Tang. | Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Antibiotics (Basel). 2021 Aug 22;10(8):1020. | 2021 |
| Ching-Yi Chen, Wang-Chun Chen, Chi-Kuei Hsu, Chien-Ming Chao, Chih-Cheng Lai. | Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials. | Int Immunopharmacol. 2021 Jul 31;99:108027. doi: 10.1016/j.intimp.2021.108027. Epub ahead of print. | 2021 |
| Ching-Yi Chen, Cheng-Yi Wang, Chih-Cheng Lai. | Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis. | JAMA. 2021 Sep 21;326(11):1070-1071. doi: 10.1001/jama.2021.11810. | 2021 |
| Ching-Yi Chen, Chao-Hsien Chen, Cheng-Yi Wang, Chih-Cheng Lai, Chien-Ming Chao, Yu-Feng Wei. | The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. | Respir Res. 2021 Sep 15;22(1):243. doi: 10.1186/s12931-021-01839-0. | 2021 |
| hing-Yi Chen, Cheng-Yi Wang, Chih-Cheng Lai. | Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis. | JAMA. 2021 Sep 21;326(11):1070-1071. doi: 10.1001/jama.2021.11810. | 2021 |
| Ching-Yi Chen, Wang-Chun Chen, Chi-Hsien Huang, Yi-Ping Hsiang, Chau-Chyun Sheu, Yung-Che Chen, Meng-Chih Lin, Kuo-An Chu, Cheng-Hung Lee, Yu-Feng Wei. | LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis. | Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937194. doi: 10.1177/1753466620937194. | 2020 |
| 陳靜宜(Ching-Yi Chen) ； 魏裕峰(Yu-Feng Wei) ； 邱建通(Chien-Tung Chiu) | Pulmonary Melioidosis Associated with Organizing Pneumonia: A Case Report= 類鼻疽桿菌肺炎併器質化肺炎：案例報告 | Thorac Med 2019; 34: 64-70. | 2019 |